Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 24 Jul 2026 for Intellia Therapeutics, Inc., €80k.
Filing timeline
BuySaleEdward J. Dulac III
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Edward J. Dulac III: trading record in brief
Edward J. Dulac III, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Fate Therapeutics Inc and Intellia Therapeutics, Inc. In total, 30 filings cover trades dated from 17 August 2020 to 22 July 2026.
No open-market purchase appears, only 21 sales worth €2.8M. Other entries cover 7 share grants and 2 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
The latest filing, published on 24 July 2026, reports an open-market sale of €80k in Intellia Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward J. Dulac III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
8,111 shares@ US$11.250.0059% mcap27.3% of flowCommon StockSEC:0001193125-26-316279:0
4,677 shares@ US$18.000.0053% mcap100.0% of flowCommon StockSEC:0001821530-26-000002:0
61,280 shares0Common StockSEC:0001193125-26-088254:0
6,379 shares@ US$9.2123.6% of flowCommon StockSEC:0001193125-26-006275:0
7,462 shares@ US$14.0254.7% of flowCommon StockSEC:0000950170-25-098774:0
47,200 shares0Common StockSEC:0000950170-25-032192:0
66,324 shares0Common StockSEC:0000950170-24-086061:0
2,447 shares@ US$7.770.7% of flowCommon StockSEC:0000950170-24-025992:0
1,849 shares@ US$5.000.3% of flowCommon StockSEC:0000950170-24-008803:0
7,028 shares@ US$4.371.1% of flowCommon StockSEC:0000950170-24-003647:0
5,182 shares@ US$3.660.6% of flowCommon StockSEC:0000950170-24-000874:0
1,585 shares@ US$3.500.2% of flowCommon StockSEC:0001209191-23-059103:0
4,718 shares@ US$2.800.5% of flowCommon StockSEC:0001209191-23-046691:0
5,182 shares@ US$4.830.9% of flowCommon StockSEC:0001209191-23-041607:0
7,331 shares@ US$5.241.3% of flowCommon StockSEC:0001209191-23-002975:0
4,703 shares@ US$29.755.2% of flowCommon StockSEC:0001209191-22-046929:0
33,302 shares0Common StockSEC:0000899243-22-003443:0
1,380 shares@ US$48.254.0% of flowCommon StockSEC:0001209191-22-003168:0
14,437 shares@ US$35.5231.0% of flowCommon StockSEC:0001209191-21-070768:0
59,540 shares0Common StockSEC:0001209191-21-066159:0
17,325 shares@ US$35.5235.7% of flowCommon StockSEC:0001209191-21-058176:0
1,937 shares@ US$87.909.9% of flowCommon StockSEC:0001209191-21-052742:0
22 of 22 declarations
